Literature DB >> 7218432

Glycosylation sites of influenza viral glycoproteins: characterization of tryptic glycopeptides from the A/USSR(H1N1) hemagglutinin glycoprotein.

S Basak, D G Pritchard, A S Bhown, R W Compans.   

Abstract

Glycosylated tryptic peptides of the hemagglutinin (HA) glycoprotein of influenza A/USSR/90/77(H1N1) virus were separated by a combination of ion-exchange chromatography and gel filtration. Seven different glycosylated tryptic peptide classes were obtained from the HA1 polypeptide, and only one glycosylated peptide was obtained from the HA2 polypeptide. Several of the tryptic fragments of HA1 and the HA2 glycopeptides were sulfated. The nature of the carbohydrate chain in each of the glycosylated tryptic peptides was determined from observations of the incorporation of different sugar precursors and susceptibility to cleavage by the enzyme endoglycosidase H and by compositional analysis by gas chromatography. Such analyses showed that three types of carbohydrate chains were present in HA1 (type I [complex], type II [high mannose], and hybrid type), whereas HA2 contained only type I oligosaccharide chains. The amino acid composition of each of the glycosylated tryptic peptides was also determined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7218432      PMCID: PMC171041     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Incorporation of sulfate into influenza virus glycoproteins.

Authors:  R W Compans; A Pinter
Journal:  Virology       Date:  1975-07       Impact factor: 3.616

2.  Separation of two polypeptide chains from the hemagglutinin subunit of influenza virus.

Authors:  W G Laver
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

3.  Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes.

Authors:  S G Lazarowitz; R W Compans; P W Choppin
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

4.  Glycopeptides of the membrane glycoprotein of Sindbis virus.

Authors:  B W Burge; J H Strauss
Journal:  J Mol Biol       Date:  1970-02-14       Impact factor: 5.469

5.  Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins.

Authors:  R W Compans; H D Klenk; L A Caliguiri; P W Choppin
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

6.  Purification and properties of an endo-beta-N-acetylglucosaminidase from Streptomyces griseus.

Authors:  A L Tarentino; F Maley
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

7.  Endo-beta-N-acetylglucosaminidases acting on the carbohydrate moieties of glycoproteins. The differential specificities of the enzymes from Streptomyces griseus and Diplococcus pneumoniae.

Authors:  M Arakawa; T Muramatsu
Journal:  J Biochem       Date:  1974-08       Impact factor: 3.387

8.  The polypeptide composition of influenza A viruses.

Authors:  J J Skehel; G C Schild
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

9.  Identification in a recombinant influenza virus of structural proteins derived from both parents.

Authors:  W G Laver; E D Kilbourne
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

10.  Studies on the primary structure of the influenza virus hemagglutinin.

Authors:  J J Skehel; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

View more
  13 in total

1.  N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGN.

Authors:  Sarah L Londrigan; Stuart G Turville; Michelle D Tate; Yi-Mo Deng; Andrew G Brooks; Patrick C Reading
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

2.  Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus.

Authors:  S Li; J Schulman; S Itamura; P Palese
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

3.  Rous sarcoma virus glycoproteins contain hybrid-type oligosaccharides.

Authors:  L A Hunt; S E Wright
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

4.  Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry.

Authors:  Jacqueline P Upham; Danielle Pickett; Tatsuro Irimura; E Margot Anders; Patrick C Reading
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

5.  RNA-sequencing analysis of 5' capped RNAs identifies many new differentially expressed genes in acute hepatitis C virus infection.

Authors:  Neven Papic; Christopher I Maxwell; Don A Delker; Shuanghu Liu; Bret S E Heale; Curt H Hagedorn
Journal:  Viruses       Date:  2012-04-16       Impact factor: 5.048

Review 6.  Soluble host defense lectins in innate immunity to influenza virus.

Authors:  Wy Ching Ng; Michelle D Tate; Andrew G Brooks; Patrick C Reading
Journal:  J Biomed Biotechnol       Date:  2012-05-16

7.  Chemoenzymatic site-specific labeling of influenza glycoproteins as a tool to observe virus budding in real time.

Authors:  Maximilian Wei-Lin Popp; Roos A Karssemeijer; Hidde L Ploegh
Journal:  PLoS Pathog       Date:  2012-03-22       Impact factor: 6.823

Review 8.  Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.

Authors:  Michelle D Tate; Emma R Job; Yi-Mo Deng; Vithiagaran Gunalan; Sebastian Maurer-Stroh; Patrick C Reading
Journal:  Viruses       Date:  2014-03-14       Impact factor: 5.048

9.  Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D.

Authors:  Kevan L Hartshorn; Richard Webby; Mitchell R White; Tesfaldet Tecle; Clark Pan; Susan Boucher; Rodney J Moreland; Erika C Crouch; Ronald K Scheule
Journal:  Respir Res       Date:  2008-09-23

Review 10.  Correlation of glycosylation forms with position in amino acid sequence.

Authors:  L Pollack; P H Atkinson
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.